Reporting of minimum clinically important differences in surgical trials.

Area of Science:

• Clinical Trials
• Surgical Research
• Biostatistics

Background:

• The minimum clinically important difference (MCID) is crucial for determining clinically relevant outcomes in research.
• Accurate MCID values are essential for appropriate sample size estimation in clinical trials.
• This study investigates the reporting and application of MCID in surgical trials.

Purpose of the Study:

• To evaluate the reporting of the minimum clinically important difference (MCID) in surgical trials.
• To assess the impact of MCID reporting on sample size calculations and study outcomes.

Main Methods:

• A systematic evaluation of surgical trials published between 1981 and 2006.
• Analysis focused on two-group trials reporting primary outcomes as proportions.
• Assessment of MCID reporting and its relation to sample size estimation.

Main Results:

• Only 21% of eligible surgical trials reported an MCID value for sample size estimation.
• A trend towards increased reporting of sample size estimates was observed over time.
• Post-hoc analysis indicated that one-third of trials required at least five times the accrued patients based on observed differences.
• Reporting sample size was linked to larger patient numbers but not necessarily more positive results.

Conclusions:

• While reporting of formal sample size estimates has increased in surgical trials over three decades, the methodology is often flawed.
• Failure to provide realistic minimum clinically important difference (MCID) values compromises the construct of these estimates.
• Improved reporting and application of MCID are necessary for more robust surgical trial design and interpretation.